Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.
Related Posts
Biocon among 4 midcap stocks that hit 52-week highs and rallied up to 21% in a month
Despite the Sensex falling 561 points on Tuesday, four BSE 150 Midcap stocks—The Phoenix Mills, Ipca Laboratories, Laurus Labs and Biocon—scaled fresh 52-week highs, signalling strong buying interest and sustained bullish momentum amid broader market weakness.
ICICI Bank Share Price Live Updates: ICICI Bank’s quarterly returns stand out
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
MedPlus Health shares tumble 16% after Q1 profit falls 21% YoY. Should you buy, sell or hold?
MedPlus Health Services shares tumbled after the company reported a weaker-than-expected Q1FY27. Despite healthy 21.9% revenue growth to ₹1,880 crore, investors were disappointed by the profitability miss. Brokerage Nomura maintained its ‘Buy’ rating, highlighting MedPlus’ long-term growth potential driven by its store expansion strategy.